For a systematic review, the present study made an extensive review around the formulated question by identifying, selecting and critically appraising data based on a comprehensive and reproducible search strategy. It was found that there exists a significant literature which speaks positively about the role of Ivermectin in prophylaxis. The drug has been found statistically significant in mortality reduction, clinical recovery time and viral clearance. Contrary to what the WHO has claimed, Ivermectin prophylaxis was associated with a very low rate of disease progression. 

Ivermectin, SARS-CoV-2, replication, nasopharyngeal swabs, pharmacovigilance, prophylaxis, treatment, qualitative data, quantitative data, protocol, HRCT of chest, RT-PCR test, statistics, case-control study, mortality reduction, clinical recovery time, viral clearance, mortality and morbidity reduction, statistically significant, HCQ prophylaxis, vitamin C prophylaxis, randomized controlled trials, prophylactic chemotherapy (PCT), FLCCC (Front Line COVID-19 Critical Care Alliance)